Cencora, Inc. (COR)
Cencora, Inc. (COR), formerly known as McKesson Corporation, is a global health care company that distributes pharmaceuticals, healthcare products, and medical supplies. It provides supply chain management, technology solutions, and healthcare services to hospitals, pharmacies, and other healthcare providers. The company plays a key role in ensuring the efficient flow of essential medical products across the healthcare industry.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 3, 2025 | $0.55 | 2025-08-15 | 2025-08-15 |
| June 2, 2025 | $0.55 | 2025-05-16 | 2025-05-16 |
| March 3, 2025 | $0.55 | 2025-02-14 | 2025-02-14 |
| November 29, 2024 | $0.55 | 2024-11-15 | 2024-11-15 |
| August 26, 2024 | $0.51 | 2024-08-09 | 2024-08-09 |
Dividends Summary
- Cencora, Inc. has issued 87 dividend payments over the past 21 years
- The most recent dividend was paid 49 days ago, on September 3, 2025
- The highest dividend payed out to investors during this period was $0.55 per share
- The average dividend paid during this period was $0.26 per share.
Company News
Cencora reported strong Q3 financial results with sales increasing 8.7% to $80.66 billion, driven by growth in healthcare solutions and GLP-1 class product sales. The company raised its full-year adjusted EPS guidance and expects continued revenue growth.
The global cell and gene therapy third-party logistics market is projected to grow from $8.66 billion in 2024 to $20.98 billion by 2033, driven by technological advancements, increasing clinical studies, and personalized medicine demands.
Walgreens is facing cash flow issues, with negative operating cash flow in recent quarters and high current liabilities compared to current assets. The company has had to sell its stake in Cencora to raise cash, and its dividend cut earlier this year may not be enough to address the underlying problems.
Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court related to a previously settled litigation. Here we discuss the key factors that likely led to the decline.
